Behind the markets

Daily Trades

July 2023 Issue: Amicus Therapeutics Inc. (SYM: FOLD)

Learn More

September 2022 Issue: Mirati Therapeutics (SYM: MRTX)

Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.
Learn More

UPDATE: Rhythm Pharmaceuticals (SYM: RYTM) Up 135%

A quick update and share some exciting news about one of our “Strong Buy” recommendations, Rhythm Pharmaceuticals (RYTM).
Learn More

January 2022 Issue: FDA Approvable Letter Calendar & Updates

Learn More

June 2021 Issue: Not all Obesity is the Same -Rhythm Pharmaceuticals

Learn More

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Get Deal

Categories

Behind the Markets

1.7K subscribers

Independent Research for Independent Investors

Behind the Markets
✅ REGISTER FOR "The Trump Takeover Summit" WEBINAR HERE 👇🏼👇🏼 https://event.webinarjam.com/channel/trumptakeoversummit Good morning, everyone! Dylan Jovine here from Behind the Markets. Happy Tuesday—it’s January 21st, and we officially have a new president in office. While the peaceful transfer of power is always an incredible moment, what’s even more exciting is the massive investment opportunity this shift represents. Today at 1 PM, we’re hosting a webinar to reveal what I believe is the biggest opportunity of Trump’s presidency: takeovers. With the stock market already near all-time highs and a P/E ratio of 30, the real action isn’t going to come from stocks themselves. Instead, we’re looking at a perfect storm of factors fueling a takeover boom. Corporations are sitting on mountains of cash, pent-up deals have been blocked by the prior administration, and now we have a new, pro-business administration ready to let these deals fly. It’s what Citibank’s Jane Fraser calls “The Big Unlock,” and I couldn’t agree more. In today’s webinar, I’ll share three top takeover targets that could benefit the most under the Trump administration. These companies have been in talks with major players like Amazon, NVIDIA, and Gilead, with offers previously blocked by regulatory hurdles. Now, with fewer restrictions and a more deal-friendly environment, we’re looking at some incredible opportunities for 2025. Make sure you don’t miss this one—it could change the game for your portfolio. I’ll see you at 1 PM! ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ SIGN UP FOR DYLAN'S DIARY HERE 👇🏼👇🏼 https://go.behindthemarkets.com/dylans-diary-sign-up/ ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LlpfSnJMYjYxMmpR

Dylan Jovine | Trump’s Pro-Business Agenda Sparks M&A Frenzy—Top Targets Revealed

✅ REGISTER FOR "The Trump Takeover Summit" WEBINAR HERE 👇🏼👇🏼 https://event.webinarjam.com/channel/trumptakeoversummit Good morning, everyone! Dylan Jovine here from Behind the Markets. Today is a special day—Inauguration Day. I’ve always loved a good inauguration speech, from JFK’s inspiring words to Reagan’s bold vision. They remind me of the incredible gift we have in this country: the peaceful transfer of power. It’s a tradition I cherish, and yes, I’ll be forcing my kids to watch it with me later today! But let’s shift gears to something else that has me excited: the current state of Wall Street banks and the massive wave of takeovers coming our way. Last week, the big players—Goldman Sachs, JPMorgan, Morgan Stanley, and others—reported stellar earnings. Their executives are calling this a once-in-a-decade moment for mergers and acquisitions, with multi-billion-dollar deals about to flow like water. They’re even calling it “The Big Unlock.” So, what’s driving this frenzy? Big Pharma is racing to address a looming patent cliff, robotics are being revolutionized by AI, and companies across industries are sitting on a trillion dollars in cash, ready to deploy. Deals in robotics, pharmaceuticals, and energy are about to reshape the market, and we’re positioning ourselves to take advantage. Want to know how? Join our webinar tomorrow, where I’ll reveal my top picks for the most exciting opportunities of 2025. Trust me, you won’t want to miss this. ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ SIGN UP FOR DYLAN'S DIARY HERE 👇🏼👇🏼 https://go.behindthemarkets.com/dylans-diary-sign-up/ ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LjYtalM1bEptX3Iw

Dylan Jovine | Wall Street’s 'Big Unlock': The Takeover Wave of 2025

✅ REGISTER FOR "The Trump Takeover Summit" WEBINAR HERE 👇🏼👇🏼 https://event.webinarjam.com/channel/trumptakeoversummit Good morning, it’s Dylan Jovine from Behind the Markets. Today, I’m diving into one of the biggest opportunities I see in the stock market as we head into the Trump administration: the upcoming M&A boom. For years, Biden’s FTC and Justice Department have made corporate takeovers incredibly difficult, creating a bottleneck of pent-up demand. But now, the floodgates are about to open, and I believe we’re about to witness a historic wave of mergers and acquisitions. During Biden’s presidency, we still managed a 96% success rate on recommended takeover targets, despite the challenges. Companies like Pfizer, Amgen, and Microsoft fought hard to close deals, and our subscribers saw significant gains. Now, with Big Pharma sitting on nearly a trillion dollars in cash and other sectors eager to act, we’re looking at a potential merger frenzy—and bigger profits for investors like you. On Tuesday, we’re hosting a special webinar to break this down in detail. I’ll reveal why this opportunity is so significant and share some of my top takeover targets. Don’t miss this chance to see what’s happening behind the scenes and get ahead of the curve. Happy days are here again—join us and find out why! ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ SIGN UP FOR DYLAN'S DIARY HERE 👇🏼👇🏼 https://go.behindthemarkets.com/dylans-diary-sign-up/ ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LmZ1WlF0S2xLRkR3

Dylan Jovine | Trump’s Presidency Could Trigger a Massive M&A Boom

Load More... Subscribe

Recent posts

3 MAGA Stocks to Buy Today – 1/21

The Trump Takeover Boom is kicking off now…

How to Trade Trump’s National Energy Emergency

Two Discounted Stocks to Buy Now – 1/20

Tags

Connect with Us

Icon-facebook Icon-btmshare_tw

July 2023 Issue: Amicus Therapeutics Inc. (SYM: FOLD)

Learn More

September 2022 Issue: Mirati Therapeutics (SYM: MRTX)

Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.
Learn More

UPDATE: Rhythm Pharmaceuticals (SYM: RYTM) Up 135%

A quick update and share some exciting news about one of our “Strong Buy” recommendations, Rhythm Pharmaceuticals (RYTM).
Learn More

January 2022 Issue: FDA Approvable Letter Calendar & Updates

Learn More

June 2021 Issue: Not all Obesity is the Same -Rhythm Pharmaceuticals

Learn More

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
Behind the markets

Company

Explore

CUSTOMER SERVICE

  • We’re here to help.
    Contact Us:
    Mon – Fri | 10 AM – 7 PM EST
  • 1-800-851-1965

© 2025 Behind the Markets, LLC. All rights reserved.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.